BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, Tkachuk VA, Markov AG, Lehnert H, de Angelis MH, Rietzsch H, Rodionov RN, Khunti K, Hopkins D, Birkenfeld AL, Boehm B, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Alberti KGMM, Geloneze B, Chan JC, Mbanya JC, Onyegbutulem HC, Ramachandran A, Basit A, Hassanein M, Bewick G, Spinas GA, Beuschlein F, Landgraf R, Rubino F, Mingrone G, Bornstein SR. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol 2021;9:786-98. [PMID: 34619105 DOI: 10.1016/S2213-8587(21)00244-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 43.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao XI, Han L, Sun Y, He D, Zhao S, Ran J. Temporal variation of excess deaths from diabetes during the COVID-19 pandemic in the United States. J Infect Public Health 2023;16:483-9. [PMID: 36801628 DOI: 10.1016/j.jiph.2023.01.018] [Reference Citation Analysis]
2 Liu L, May NS, Sato PY, Srivastava P, McClure LA. Association between Cardiovascular Risk and Coronavirus Disease 2019: Findings from 2021 National Health Interview Survey. Ann Epidemiol 2023:S1047-2797(23)00054-6. [PMID: 36963621 DOI: 10.1016/j.annepidem.2023.03.005] [Reference Citation Analysis]
3 Nobili A, D'Avanzo B, Tettamanti M, Galbussera AA, Remuzzi G, Fortino I, Leoni O, Harari S, Mannucci PM. Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact. Intern Emerg Med 2023. [PMID: 36944811 DOI: 10.1007/s11739-023-03228-5] [Reference Citation Analysis]
4 Rubí Romo-Rodríguez, Karla Gutiérrez-de Anda, Jebea A López-Blanco, Gabriela Zamora-Herrera, Paulina Cortés-Hernández, Gerardo Santos-López, Luis Márquez-Domínguez, Armando Vilchis-Ordoñez, Dalia Ramírez-Ramírez, Juan Carlos Balandrán, Israel Parra-Ortega, Osbaldo Resendis-Antonio, Lenin Domínguez-Ramírez, Constantino López-Macías, Laura C. Bonifaz, Lourdes A. Arriaga-Pizano, Arturo Cérbulo-Vázquez, Eduardo Ferat-Osorio, Antonieta Chavez-González, Samuel Treviño, Eduardo Brambila, Miguel Ángel Ramos-Sánchez, Ricardo Toledo-Tapia, Fabiola Domínguez, Jorge Bayrán-Flores, Alejandro Cruz-Oseguera, Julio Roberto Reyes-Leyva, Socorro Méndez-Martínez, Jorge Ayón-Aguilar, Aurora Treviño-García, Eduardo Monjaraz, Rosana Pelayo. Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes. Arch Med Res 2023. [ DOI: 10.1016/j.arcmed.2023.03.003] [Reference Citation Analysis]
5 Zhang T, Wang N, Zhu L, Chen L, Liu H. Bidirectional Relationship between Glycemic Control and COVID-19 and Perspectives of Islet Organoid Models of SARS-CoV-2 Infection. Biomedicines 2023;11:856. [DOI: 10.3390/biomedicines11030856] [Reference Citation Analysis]
6 Misra AK, Rangari G, C M, Sharma S. Current management of diabetes patients with COVID-19. Expert Rev Endocrinol Metab 2023;:1-9. [PMID: 36890686 DOI: 10.1080/17446651.2023.2187375] [Reference Citation Analysis]
7 Misra AK, Rangari G, C M, Sharma S. Current management of diabetes patients with COVID-19. Expert Rev Endocrinol Metab 2023;:1-9. [PMID: 36882971 DOI: 10.1080/17446651.2023.2187215] [Reference Citation Analysis]
8 Steenblock C, Toepfner N, Beuschlein F, Perakakis N, Mohan Anjana R, Mohan V, Mahapatra NR, Bornstein SR. SARS-CoV-2 infection and its effects on the endocrine system. Best Pract Res Clin Endocrinol Metab 2023;:101761. [PMID: 36907787 DOI: 10.1016/j.beem.2023.101761] [Reference Citation Analysis]
9 Vrieling F, Stienstra R. Obesity and dysregulated innate immune responses: impact of micronutrient deficiencies. Trends Immunol 2023;44:217-30. [PMID: 36709082 DOI: 10.1016/j.it.2023.01.003] [Reference Citation Analysis]
10 Fan X, Han J, Zhao E, Fang J, Wang D, Cheng Y, Shi Y, Wang Z, Yao Z, Lu P, Liu T, Li Q, Poulsen KL, Yuan Z, Song Y, Zhao J. The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: A population-based study. Cell Metab 2023:S1550-4131(23)00052-9. [PMID: 36931274 DOI: 10.1016/j.cmet.2023.02.016] [Reference Citation Analysis]
11 Tudoran C, Bende R, Bende F, Giurgi-oncu C, Enache A, Dumache R, Tudoran M. Connections between Diabetes Mellitus and Metabolic Syndrome and the Outcome of Cardiac Dysfunctions Diagnosed during the Recovery from COVID-19 in Patients without a Previous History of Cardiovascular Diseases. Biology 2023;12:370. [DOI: 10.3390/biology12030370] [Reference Citation Analysis]
12 Mohamadian H, Faraji A, Ghorrabi AT, Ghobadi-Dashdebi K, Salahshouri A. The COVID-19 pandemic: knowledge, attitudes and practices of coronavirus (COVID-19) among patients with type 2 diabetes. J Health Popul Nutr 2023;42:11. [PMID: 36805712 DOI: 10.1186/s41043-023-00349-7] [Reference Citation Analysis]
13 Galstyan GR. The use of long-acting insulin degludec in adult patients with type 2 diabetes mellitus in real clinical practice in Russia. Diabetes mellitus 2023;26:55-65. [DOI: 10.14341/dm12976] [Reference Citation Analysis]
14 Tudoran C, Bende F, Bende R, Giurgi-Oncu C, Dumache R, Tudoran M. Correspondence between Aortic and Arterial Stiffness, and Diastolic Dysfunction in Apparently Healthy Female Patients with Post-Acute COVID-19 Syndrome. Biomedicines 2023;11. [PMID: 36831027 DOI: 10.3390/biomedicines11020492] [Reference Citation Analysis]
15 Khunti K, Valabhji J, Misra S. Diabetes and the COVID-19 pandemic. Diabetologia 2023;66:255-66. [PMID: 36418578 DOI: 10.1007/s00125-022-05833-z] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Valyaeva AA, Zharikova AA, Sheval EV. SARS-CoV-2 cellular tropism and direct multiorgan failure in COVID-19 patients: Bioinformatic predictions, experimental observations, and open questions. Cell Biol Int 2023;47:308-26. [PMID: 36229927 DOI: 10.1002/cbin.11928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Altshuler E, Tannir B, Jolicoeur G, Rudd M, Saleem C, Cherabuddi K, Doré DH, Nagarsheth P, Brew J, Small PM, Glenn Morris J, Grandjean Lapierre S. Digital cough monitoring - A potential predictive acoustic biomarker of clinical outcomes in hospitalized COVID-19 patients. J Biomed Inform 2023;138:104283. [PMID: 36632859 DOI: 10.1016/j.jbi.2023.104283] [Reference Citation Analysis]
18 Normatov MG, Karev VE, Kolobov AV, Mayevskaya VA, Ryabkova VA, Utekhin VJ, Churilov LP. Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates. Diagnostics (Basel) 2023;13. [PMID: 36766627 DOI: 10.3390/diagnostics13030522] [Reference Citation Analysis]
19 Zhao SW, Li YM, Li YL, Su C. Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments. World J Gastroenterol 2023; 29(2): 241-256 [PMID: 36687127 DOI: 10.3748/wjg.v29.i2.241] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Baranova A, Song Y, Cao H, Zhang F. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149-54. [PMID: 36215434 DOI: 10.2337/db22-0610] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Diamanti-kandarakis E, Papalou O, Soulage CO. Effectiveness of Myo- and d-chiro-inositol in the treatment of metabolic disorders. A Clinical Guide to Inositols 2023. [DOI: 10.1016/b978-0-323-91673-8.00005-4] [Reference Citation Analysis]
22 Lai H, Yang M, Sun M, Pan B, Wang Q, Wang J, Tian J, Ding G, Yang K, Song X, Ge L. Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis. Metabolism 2022;137:155330. [PMID: 36220361 DOI: 10.1016/j.metabol.2022.155330] [Reference Citation Analysis]
23 Alkhemeiri A, Al Zaabi S, Lakshmanan J, El-Khatib Z, Awofeso N. COVID-19 Case Management Outcomes Amongst Diabetes and Hypertensive Patients in the United Arab Emirates: A Prospective Study. Int J Environ Res Public Health 2022;19. [PMID: 36498037 DOI: 10.3390/ijerph192315967] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ssentongo P, Zhang Y, Witmer L, Chinchilli VM, Ba DM. Association of COVID-19 with diabetes: a systematic review and meta-analysis. Sci Rep 2022;12:20191. [PMID: 36418912 DOI: 10.1038/s41598-022-24185-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fericean RM, Rosca O, Citu C, Manolescu D, Bloanca V, Toma AO, Boeriu E, Dumitru C, Ravulapalli M, Barbos V, Oancea C. COVID-19 Clinical Features and Outcomes in Elderly Patients during Six Pandemic Waves. J Clin Med 2022;11. [PMID: 36431282 DOI: 10.3390/jcm11226803] [Reference Citation Analysis]
26 Kshirsagar M, Nasir M, Mukherjee S, Becker N, Dodhia R, Weeks WB, Ferres JL, Richardson B. The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data. JMIR Public Health Surveill 2022;8:e38898. [PMID: 36265135 DOI: 10.2196/38898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Di Lorenzo A, Tedde S, Pace PG, Campogiani L, Ansaldo L, Lodi A, Zordan M, Barreca F, Caldara F, Rossi B, Imeneo A, Alessio G, Crea AMA, Checchi D, Malagnino V, Teti E, Coppola L, Palmieri R, Buccisano F, Andreoni M, Sarmati L, Iannetta M. Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients. Biomedicines 2022;10. [PMID: 36359306 DOI: 10.3390/biomedicines10112788] [Reference Citation Analysis]
28 Judith Ju Ming Wong, Qalab Abbas, Felix Liauw, Ririe Fachrina Malisie, Chin Seng Gan, Muhammad Abid, Pustika Efar, Josephine Gloriana, Soo Lin Chuah, Rehena Sultana, Koh Cheng Thoon, Chee Fu Yung, Jan Hau Lee, PACCOVRA Investigators of the PACCMAN research group. Development and validation of a clinical predictive model for severe and critical pediatric COVID-19 infection. PLoS One 2022;17:e0275761. [PMID: 36301941 DOI: 10.1371/journal.pone.0275761] [Reference Citation Analysis]
29 Wrona M, Skrypnik D. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review. Int J Environ Res Public Health 2022;19. [PMID: 36293857 DOI: 10.3390/ijerph192013280] [Reference Citation Analysis]
30 Kumar R, Kumar V, Arya R, Anand U, Priyadarshi RN. Association of COVID-19 with hepatic metabolic dysfunction. World J Virol 2022; 11(5): 237-251 [DOI: 10.5501/wjv.v11.i5.237] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Liao S, Omage SO, Börmel L, Kluge S, Schubert M, Wallert M, Lorkowski S. Vitamin E and Metabolic Health: Relevance of Interactions with Other Micronutrients. Antioxidants (Basel) 2022;11:1785. [PMID: 36139859 DOI: 10.3390/antiox11091785] [Reference Citation Analysis]
32 Arghittu A, Deiana G, Castiglia E, Pacifico A, Brizzi P, Cossu A, Castiglia P, Dettori M. Knowledge, Attitudes, and Behaviors towards Proper Nutrition and Lifestyles in Italian Diabetic Patients during the COVID-19 Pandemic. Int J Environ Res Public Health 2022;19. [PMID: 36141484 DOI: 10.3390/ijerph191811212] [Reference Citation Analysis]
33 Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm (2020) 2022;3:e157. [PMID: 35958432 DOI: 10.1002/mco2.157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Churilov LP, Normatov MG, Utekhin VJ. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity? Pathophysiology 2022;29:486-94. [DOI: 10.3390/pathophysiology29030039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Da Porto A, Tascini C, Colussi G, Peghin M, Graziano E, De Carlo C, Bulfone L, Antonello M, Sozio E, Fabris M, Curcio F, Pucillo C, Catena C, Sechi LA. Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection. Front Med 2022;9. [DOI: 10.3389/fmed.2022.988686] [Reference Citation Analysis]
36 Shestakova MV, Vikulova OK, Elfimova AR, Deviatkin AA, Dedov II, Mokrysheva NG. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation. Front Endocrinol 2022;13:909874. [DOI: 10.3389/fendo.2022.909874] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yoshiji S, Tanaka D, Minamino H, Lu T, Butler-laporte G, Murakami T, Fujita Y, Richards JB, Inagaki N. Causal associations between body fat accumulation and COVID-19 severity: A Mendelian randomization study. Front Endocrinol 2022;13:899625. [DOI: 10.3389/fendo.2022.899625] [Reference Citation Analysis]
38 Hopkins D, Rubino F. The effect of COVID-19 on routine diabetes care and mortality in people with diabetes. Lancet Diabetes Endocrinol 2022;10:550-1. [PMID: 35636442 DOI: 10.1016/S2213-8587(22)00162-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Chen H, Chen Q. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD. Int J Biol Sci 2022;18:4756-67. [PMID: 35874945 DOI: 10.7150/ijbs.72461] [Reference Citation Analysis]
40 Hadizadeh N, Naderi M, Khezri J, Yazdani M, Shamsara M, Hashemi E. Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01002-6] [Reference Citation Analysis]
41 Khalimov YS, Agafonov PV, Kireeva EB. Obesity and COVID-19: insights from two pandemics. jour 2022;14:27-38. [DOI: 10.22625/2072-6732-2022-14-2-27-38] [Reference Citation Analysis]
42 López-gonzález ÁA, Altisench Jané B, Masmiquel Comas L, Arroyo Bote S, González San Miguel HM, Ramírez Manent JI. Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study. Nutrients 2022;14:2795. [DOI: 10.3390/nu14142795] [Reference Citation Analysis]
43 Graziano E, Peghin M, De Martino M, De Carlo C, Da Porto A, Bulfone L, Casarsa V, Sozio E, Fabris M, Cifù A, Grassi B, Curcio F, Isola M, Sechi LA, Tascini C, Croatto L, Ditaranto P, Ditaranto LM. The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.07.003] [Reference Citation Analysis]
44 Bornstein SR, Ludwig B, Steenblock C. Progress in islet transplantation is more important than ever. Nat Rev Endocrinol 2022;18:389-90. [PMID: 35578026 DOI: 10.1038/s41574-022-00689-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
45 Tudoran C, Tudoran M, Cut TG, Lazureanu VE, Bende F, Fofiu R, Enache A, Pescariu SA, Novacescu D. The Impact of Metabolic Syndrome and Obesity on the Evolution of Diastolic Dysfunction in Apparently Healthy Patients Suffering from Post-COVID-19 Syndrome. Biomedicines 2022;10:1519. [PMID: 35884823 DOI: 10.3390/biomedicines10071519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Rudiansyah M, Jasim SA, Mohammad Pour ZG, Athar SS, Jeda AS, Doewes RI, Jalil AT, Bokov DO, Mustafa YF, Noroozbeygi M, Karampoor S, Mirzaei R. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism. J Med Virol 2022. [PMID: 35689351 DOI: 10.1002/jmv.27929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Schechter M, Fischer M, Mosenzon O. Preventing all-cause hospitalizations in type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A narrative review and proposed clinical approach. Diabetes Obes Metab 2022;24:969-82. [PMID: 35212443 DOI: 10.1111/dom.14675] [Reference Citation Analysis]
48 Dwyer KM, Robson B, Muecke J. Too much sugar does not just make us fat; it can also make us sick. Internal Medicine Journal. [DOI: 10.1111/imj.15812] [Reference Citation Analysis]
49 Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 2022;10:311-21. [PMID: 35325624 DOI: 10.1016/S2213-8587(22)00044-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 66] [Article Influence: 125.0] [Reference Citation Analysis]
50 Schnell O, Battelino T, Bergenstal R, Blüher M, Böhm M, Brosius F, Carr RD, Ceriello A, Forst T, Giorgino F, Guerci B, Heerspink HJL, Itzhak B, Ji L, Kosiborod M, Lalić N, Lehrke M, Marx N, Nauck M, Rodbard HW, Rosano GMC, Rossing P, Rydén L, Santilli F, Schumm-Draeger PM, Vandvik PO, Vilsbøll T, Wanner C, Wysham C, Standl E. Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes. Cardiovasc Diabetol 2022;21:50. [PMID: 35395808 DOI: 10.1186/s12933-022-01481-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Sun CY, Zheng ZL, Chen CW, Lu BW, Liu D. Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases. Front Microbiol 2022;13:859206. [PMID: 35369480 DOI: 10.3389/fmicb.2022.859206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
52 Oh TJ. Letter: Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients (J Obes Metab Syndr 2021;30:149-54). J Obes Metab Syndr 2022;31:86-7. [PMID: 35263713 DOI: 10.7570/jomes21094] [Reference Citation Analysis]
53 Sardu C, Marfella R, Prattichizzo F, La Grotta R, Paolisso G, Ceriello A. Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms. JCM 2022;11:1564. [DOI: 10.3390/jcm11061564] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
54 Steenblock C, Schwarz PEH, Perakakis N, Brajshori N, Beqiri P, Bornstein SR. The interface of COVID-19, diabetes, and depression. Discov Ment Health 2022;2:5. [PMID: 35253006 DOI: 10.1007/s44192-022-00007-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
55 Caputo A, Guzman CA, Palmer CS, Nicoli F. Editorial: The Role of Systemic and Cellular Metabolism on Susceptibility to Infections and Responsiveness to Vaccination. Front Cell Infect Microbiol 2022;12:854241. [DOI: 10.3389/fcimb.2022.854241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Bechmann N, Barthel A, Schedl A, Herzig S, Varga Z, Gebhard C, Mayr M, Hantel C, Beuschlein F, Wolfrum C, Perakakis N, Poston L, Andoniadou CL, Siow R, Gainetdinov RR, Dotan A, Shoenfeld Y, Mingrone G, Bornstein SR. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol 2022;10:221-30. [PMID: 35114136 DOI: 10.1016/S2213-8587(21)00346-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 37.0] [Reference Citation Analysis]
57 Sanoudou D, Hill MA, Belanger MJ, Arao K, Mantzoros CS. Editorial: Obesity, metabolic phenotypes and COVID-19. Metabolism 2022;128:155121. [PMID: 35026232 DOI: 10.1016/j.metabol.2021.155121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
58 Tonnus W, Latk M, Linkermann A. Diabetes und Nierenerkrankungen bei COVID-19. Diabetes aktuell 2022;20:18-21. [DOI: 10.1055/a-1714-4124] [Reference Citation Analysis]
59 Bretschneider MP, Rohner M, Bornstein SR, Schwarz PEH. Prävention von COVID-19. Diabetes aktuell 2022;20:22-28. [DOI: 10.1055/a-1751-8304] [Reference Citation Analysis]
60 Steenblock C, Ludwig B, Bornstein S. Kann Diabetes durch COVID-19 ausgelöst werden? Diabetes aktuell 2022;20:12-17. [DOI: 10.1055/a-1749-2969] [Reference Citation Analysis]
61 Steenblock C, Ziegler C, Balanzew W, Barthel A, Wang J, Licinio J, Bornstein S. Metabolische und mentale Folgen der Pandemie. Diabetes aktuell 2022;20:36-42. [DOI: 10.1055/a-1753-3875] [Reference Citation Analysis]
62 Steenblock C, Hoffmann C, Rachner TD, Guggenbichler F, Tahirukaj E, Bejtullah S, Zinserling VA, Varga Z, Bornstein SR, Perakakis N. Management von Diabetespatienten in der COVID-19-Pandemie. Diabetes aktuell 2022;20:43-50. [DOI: 10.1055/a-1754-9194] [Reference Citation Analysis]
63 Bornstein S. Long-COVID und Diabetes. Diabetes aktuell 2022;20:30-35. [DOI: 10.1055/a-1751-9442] [Reference Citation Analysis]
64 Yoshiji S, Tanaka D, Minamino H, Murakami T, Fujita Y, Richards JB, Inagaki N. Causal associations between body fat accumulation and COVID-19 severity: A Mendelian randomization study.. [DOI: 10.1101/2022.01.20.22269593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Kouvari M, D'Cunha NM, Travica N, Sergi D, Zec M, Marx W, Naumovski N. Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review. Nutrients 2022;14:333. [PMID: 35057514 DOI: 10.3390/nu14020333] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
66 Leung EH, Fan J, Flynn HW Jr, Albini TA. Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare. Clin Ophthalmol 2022;16:1-13. [PMID: 35018092 DOI: 10.2147/OPTH.S336963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Ishida M. How to deal with hypertension in the COVID-19 era-the impact "ON" and "OF" hypertension. Hypertens Res 2022;45:548-50. [PMID: 34921300 DOI: 10.1038/s41440-021-00822-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Stoian AP, Kempler P, Stulnig T, Rizvi AA, Rizzo M. Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us. Metab Syndr Relat Disord 2021. [PMID: 34967689 DOI: 10.1089/met.2021.0133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Bhatti SI, Mindikoglu AL. The impact of dawn to sunset fasting on immune system and its clinical significance in Covid-19 pandemic. Metabol Open 2021;:100162. [PMID: 34977523 DOI: 10.1016/j.metop.2021.100162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
70 Wang J, Safo SE. Deep IDA: A Deep Learning Method for Integrative Discriminant Analysis of Multi-View Data with Feature Ranking -- An Application to COVID-19 severity. ArXiv 2021. [PMID: 34815984] [Reference Citation Analysis]
71 Zinserling VA, Bornstein SR, Narkevich TA, Sukhanova YV, Semenova NY, Vashukova MA, Steenblock C. Stillborn child with diffuse SARS-CoV-2 viral infection of multiple organs. IDCases 2021;26:e01328. [PMID: 34777995 DOI: 10.1016/j.idcr.2021.e01328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
72 Rizvi AA, Janez A, Rizzo M. Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci 2021;22:12311. [PMID: 34830193 DOI: 10.3390/ijms222212311] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]